A Phase 2 Study of Peginterferon Lambda, Lonafarnib and Ritonavir for 24 Weeks: End-of-Treatment Results from the LIFT HDV Study
Christopher Koh, Julian Hercun, Farial Naima Rahman, Amy Huang, Ben L. Da, Pallavi Surana, Devika Kapuria, Yaron Rotman, Anusha Vittal, Christy Gilman, Gil Ben Yakov, Walter Lai, Harel Dahari, Jeffrey S. Glenn, Theo Heller
Topics & Concepts
VirologyLift (data mining)RitonavirMedicineLambdaPhysicsHuman immunodeficiency virus (HIV)Viral loadComputer scienceData miningAntiretroviral therapyOpticsNeuroendocrine Tumor Research AdvancesElectroconvulsive Therapy Studies